Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study

Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study

Abstract Background Increased mineralocorticoid activity is one of the plausible causes of chronic central serous chorioretinopathy (CSCR) and mineralocorticoid inhibitors such as eplerenone have been investigated as its potential therapy. This study investigates the short-term safety and efficacy o...

Full description

Bibliographic Details
Main Authors: Hamid-Reza Moein, Lauren W. Bierman, Eduardo A. Novais, Carlos Moreira-Neto, Caroline R. Baumal, Adam Rogers, Jay S. Duker, André J. Witkin
Format: Article
Language:English
Published: BMC 2019-09-01
Series:International Journal of Retina and Vitreous
Subjects:
Central serous chorioretinopathy
Eplerenone
Mineralocorticoid inhibitors
Online Access:http://link.springer.com/article/10.1186/s40942-019-0190-y

Internet

http://link.springer.com/article/10.1186/s40942-019-0190-y

Similar Items